Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 4
1(33.3%)
N/A
1(33.3%)
Phase 3
1(33.3%)
3Total
Phase 4(1)
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07166302Recruiting

Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy

Role: collaborator

NCT07107477Phase 3Recruiting

TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden

Role: collaborator

NCT06887179Not ApplicableNot Yet Recruiting

Point-of-Care Ultrasound in Chronic Heart Failure

Role: collaborator

NCT05493163Phase 4Recruiting

Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism

Role: collaborator

All 4 trials loaded